Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ganesh R Iyer"'
Autor:
William T. Prince, Vinay Kumar Venishetty, Jean Lecot, Kasra Shakeri‐Nejad, Cathy Gray, Amanda Taylor, Ganesh R. Iyer, Julia Zack
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 10, Pp 1758-1767 (2023)
Abstract Triclabendazole is an effective and well‐tolerated treatment for human fascioliasis. A placebo‐ and positive‐controlled, four‐sequence by four‐period crossover study was conducted in 45 healthy participants to assess the effect of
Externí odkaz:
https://doaj.org/article/64c515edc6524a60806e568d0973610f
Publikováno v:
Clinical Pharmacology in Drug Development. 12:333-342
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9acaf7aa421afe3b429b36fed3ef7b5b
https://doi.org/10.1002/cpdd.1220
https://doi.org/10.1002/cpdd.1220
Autor:
James E. Chastain, Upendra A. Argikar, Nagendra V. Chemuturi, Markus Walles, Gian Camenisch, Vito G. Sasseville, Jennifer L. Dumouchel, Mark Milton, Ganesh R. Iyer, Mithat Gunduz
Publikováno v:
Drug Metabolism and Disposition. 46:1670-1683
The eye is a complex organ with a series of anatomic barriers that provide protection from physical and chemical injury while maintaining homeostasis and function. The physiology of the eye is multifaceted, with dynamic flows and clearance mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4f38ccecf4ce4c55b549ebeb317757f
https://doi.org/10.1124/dmd.118.082974
https://doi.org/10.1124/dmd.118.082974
Autor:
Kenneth N Sall, Ganesh R Iyer, Apinya Vutikullird, David Wirta, Abhijit Narvekar, Edward John Meier, Harvey Dubiner
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Edward Meier,1 Abhijit Narvekar,2 Ganesh R Iyer,2 Harvey B DuBiner,3 Apinya Vutikullird,4 David Wirta,5 Kenneth Sall61Apex Eye, Mason, OH, 2Alcon Research Ltd., Fort Worth, TX, 3Clayton Eye Center, Morrow,GA, 4WCCT Global, Cypress, 5Eye Research Foun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6385959bb0a9638f6ecd4ea5fe48e1e
https://www.dovepress.com/pharmacokinetics-and-safety-of-olopatadine-hydrochloride-077-in-health-peer-reviewed-article-OPTH
https://www.dovepress.com/pharmacokinetics-and-safety-of-olopatadine-hydrochloride-077-in-health-peer-reviewed-article-OPTH
Publikováno v:
Clinical pharmacology in drug development. 1(1)
The primary objective of this study is to characterize the pharmacokinetics of total (14)C concentrations following bilateral, topical ocular drops of (14)C-AL-8309B labeled either at the pyrimidyl ring (cohort A) position or at the imido-carbonyl ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a59010a58e43ebb1d6ff975be7d6410
https://pubmed.ncbi.nlm.nih.gov/27206141
https://pubmed.ncbi.nlm.nih.gov/27206141
Autor:
Stephen R. Donahue, Karl Rickels, Michael Kauffman, Sanjay J. Mathew, Ganesh R. Iyer, Daniel L. Zimbroff, John F. Reinhard, Michael D. Banov, Edward C. Parsons, Scott Oshana
Publikováno v:
Journal of Clinical Psychopharmacology. 28:235-239
PRX-00023, a serotonin 1A receptor agonist, was designed to provide high potency and selectivity for its target. To assess the possible therapeutic utility in anxiety, a randomized, double-blind, placebo-controlled trial was conducted in 311 subjects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c63486239b449e01f9d260328d179660
https://doi.org/10.1097/jcp.0b013e31816774de
https://doi.org/10.1097/jcp.0b013e31816774de
Publikováno v:
The Journal of Clinical Pharmacology. 47:817-824
PRX-00023 is a novel, nonazapirone 5-HT1A agonist in clinical development for treatment of affective disorders. The objectives of the initial clinical phase I studies (a single ascending dose study and multiple dose-ascending and high-dose titration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::745d63473d46eda492684c6be03f043a
https://doi.org/10.1177/0091270007300953
https://doi.org/10.1177/0091270007300953
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 31(4)
The primary objective of this study was to compare uptake and distribution of the commercially available formulation of 0.2% olopatadine and the newly developed 0.77% olopatadine hydrochloride ophthalmic solution formulation with improved solubility
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bab737ed6522e79f5cdda5a2f46de59
https://pubmed.ncbi.nlm.nih.gov/25775192
https://pubmed.ncbi.nlm.nih.gov/25775192
Autor:
Savas Yavuzkurt, Ganesh R. Iyer
Publikováno v:
Annals of the New York Academy of Sciences. 934:265-272
A review of the past work done on free stream turbulence (FST) as applied to gas turbine heat transfer and its implications for future studies are presented. It is a comprehensive approach to the results of many individual studies in order to derive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd1fc60e8816a6c2695a1cf1b91c8ed6
https://doi.org/10.1111/j.1749-6632.2001.tb05859.x
https://doi.org/10.1111/j.1749-6632.2001.tb05859.x
Publikováno v:
Journal of Clinical Pharmacology. 42:428-436
The objective of this study was to compare the pharmacokinetics and safety of galantamine in subjects with hepatic impairment with those in healthy subjects. This was an open-label study in which a single oral 4-mg dose of galantamine was administere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d8c4203f61639ec2fa2382e533db10
https://doi.org/10.1177/0091270002424009
https://doi.org/10.1177/0091270002424009